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Aims Many patients are afraid of dying during acute coronary syndrome (ACS), but the origins and biological correlates of
these emotional responses are poorly understood. This study evaluated the prevalence of fear of dying, associations
with inflammatory responses during ACS, and later heart rate variability (HRV) and cortisol secretion.
Methods
and results
Two hundred and eight patients admitted with clinically verified ACS rated their fear of dying on interview in hospital.
Plasma tumour necrosis factor (TNF)a was recorded on admission, and HRV and salivary cortisol were assessed 3
weeks later. Intense distress and fear of dying was experienced by 21.7%, with moderate levels in 66.1% patients. Fear
of dying was more common in younger, lower socioeconomic status, and unmarried patients. It was positively associ-
ated with plasma TNFa on admission after controlling for sociodemographic factors, clinical risk, and pain intensity
(adjusted odds ¼ 4.67, 95% C.I. 1.66–12.65). TNFa was associated with reduced HRV 3 weeks later, adjusting for
clinical and sociodemographic factors and medication (P ¼ 0.019), while fear of dying was associated with reduced
cortisol output (P ¼ 0.004).
Conclusions Intense distress and fear of dying and heightened inflammation may be related manifestations of an acute biobeha-
vioural response to severe cardiac injury, and have implications for prognostically significant biological risk processes.
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Introduction
Acute cardiac events can be very frightening experiences, and a sig-
nificant proportion of patients describe intense distress and fear of
dying during an acute coronary syndrome (ACS).1,2 Acute distress
and fear of dying are more common among physically sedentary
lower socioeconomic status (SES) patients who report strong
chest pain during their ACS, and predicts elevated symptoms of
depression in the weeks following ACS.2 Since depression follow-
ing ACS is associated with recurrent cardiac events and impaired
quality of life,3,4 investigation of the biological correlates of fear
of dying is warranted. One possibility is that fear of dying is
coupled with heightened inflammatory responses during ACS.
Acute coronary syndrome is accompanied by a profound inflam-
matory response, and the magnitude of elevations in C-reactive
protein, tumour necrosis factor (TNF) a and interleukin (IL) 6
levels during ACS predict both short- and long-term risk of recur-
rent cardiac events and adverse outcomes.5– 8 Acute psychological
stress also stimulates increases in the concentration of TNFa, IL-6,
and IL-1 receptor antagonist (IL-1Ra) within 1 to 2 h,9 while per-
ipheral inflammation can in turn induce acute negative mood
states.10 Intense acute distress and heightened inflammation may
be manifestations of an integrated biobehavioural reaction to
acute cardiac events.
Fear of dying and acute inflammatory responses may have impli-
cations for prognostically significant biological risk processes, two
of which were investigated in this study. Inflammatory responses
have a reciprocal relationship with cardiac autonomic regulation.
An inverse association between TNFa, C-reactive protein, or
IL-6 and heart rate variability (HRV) has been observed both in
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cardiac patients and healthy samples,11 and the extent of inflam-
mation on admission with ACS is negatively correlated with
HRV.12 Investigations of the inflammatory reflex indicate that
stimulation of the vagus nerve inhibits TNFa responses to endo-
toxins,13 probably through the inhibition of acetylcholine receptors
on macrophages.14 Additionally, endotoxin administration
depresses HRV in experimental models, and these effects are
mimicked by administration of recombinant TNFa.15 Reduced
HRV is also commonly observed in response to psychological
stress.16 Cortisol secretion is also sensitive to stress, and may be
relevant following ACS since low cortisol output may lead to
failure to contain inflammatory responses.17 Reynolds et al.18
recently showed that low cortisol on admission predicted early
death after acute myocardial infarction. The first aim of this
study was therefore to evaluate the association between acute dis-
tress and fear of dying and TNFa during ACS. The second aim was
to discover whether TNFa and fear of dying during ACS corre-
lated with reduced HRV and cortisol output 3 weeks later.
Methods
Participants
The participants were 208 patients admitted with ACS to St. George’s
Hospital in South London between June 2007 and October 2008 as
part of a larger study of psychosocial aspects of ACS. Patients were
included if they fulfilled the following criteria: a diagnosis of ACS
based on the presence of chest pain plus verification by diagnostic
electrocardiographic (EKG) changes, troponin T or troponin I ≥
99th percentile of the upper reference limit and/or a creatine kinase
measurement more than twice the upper range of normal for the
measuring laboratory. Additional inclusion criteria were age of 18
years or older, absence of comorbid conditions that might influence
either symptom presentation or mood, other conditions that might
cause inflammation, and ability to complete interviews and question-
naires in English. Some of these criteria were introduced for the
sake of other analyses that are not discussed here; the main comorbid
conditions relevant to these analyses were cancer and severe anaemia.
The study was approved by the Wandsworth Research Ethics Com-
mittee (IRB), and written consent was obtained. A total of 666 poten-
tially eligible patients were admitted on the days of recruitment into
this study. Hundred and twenty-five had been discharged or trans-
ferred on to a different hospital before the patient could be recruited
into the study, 90 were too clinically fragile to take part, TNFa was not
available for 90, 58 declined to participate, 27 could not speak English,
23 were in confusional states, 7 patients died in hospital, and a further
38 were excluded for other reasons.
Clinical and sociodemographic measures
Information was obtained from medical notes about cardiovascular
history, clinical factors during admission and management. Admission
EKGs were reviewed and scrutinized for presentation as ST-elevation
myocardial infarction (STEMI) or non-STEMI /unstable angina. We
computed the composite risk index based on the algorithm developed
in the GRACE study,19 which uses nine criteria (age, congestive heart
failure, history of myocardial infarction (MI), systolic blood pressure
and heart rate on admission, ST segment depression, initial serum crea-
tinine, elevated cardiac enzymes, and in-hospital percutaneous coron-
ary intervention) to define risk of 6-month post-discharge death
applicable to all types of ACS. Peak CK level and the number of
coronary vessels with significant stenosis were included as additional
indicators of clinical severity, and the number of days spent in hospital
as a further measure of clinical status. This variable was positively
skewed so was log transformed before analysis.
Socioeconomic status was assessed using a social deprivation index
based on three criteria: living in a crowded household (defined as one
or more people to a room), renting as opposed to owning a home, and
not having use of a motor vehicle (car or van).20 Patients were classi-
fied as low deprivation (negative on all items), medium deprivation
(one positive), and high deprivation (2–3 positive). The intensity of
pain during the ACS was assessed on a 10-point scale, with higher
values indicating greater pain.
Assessment of acute distress and fear of dying
Acute distress and fear of dying were assessed during interviews
carried out in hospital an average of within 2.41+ 1.6 days of admis-
sion. Acute distress and fear were measured with 3 items, as detailed
previously: ‘I was frightened when the symptoms came on’, ‘I thought
that I might be dying when the symptoms came on’, and ‘I found my
cardiac event stressful’.2 Each was rated into 1 of 5 categories: not
at all true (0), slightly true (1), somewhat true (2), very true (3), and
extremely true (4). A combined score was created by averaging
these ratings (Cronbach a ¼ 0.82). Participants were divided into 3
groups: no distress and fear (average ratings of ‘not at all true’,
0–0.99), moderate distress and fear (average ratings of ‘slightly true’
and ‘somewhat true’, 1.0–2.99), and intense distress and fear
(average ratings of ‘very true’ and ‘extremely true’, 3.0–4). Patients
were also asked about whether they had attributed their symptoms
to heart problems.
Tumour necrosis factor a on admission
Tumour necrosis factor a was measured from blood samples obtained
on admission to hospital using an immunometric assay using an Immu-
lite 1 system (Siemens Healthcare Diagnostics). Intra-assay and inter-
assay coefficients of variation were 2.6–3.6% and 4.0–6.5%,
respectively.
Heart rate variability
Heart rate variability was analysed from EKG recordings obtained at
the patients’ homes an average of 21.9+ 8.4 days following ACS
with Actiheart monitors (Cambridge Neurotechnology Ltd, Papworth,
UK).21 The N–N intervals were processed using Kubios HRV analysis
software (University of Kuopio, Finland) in 5 min epochs in both the
time and frequency domain (using fast Fourier transform). Heart rate
variability was indexed in these analyses by the root mean square of
successive differences (RMSSD), and by high frequency (0.15–
0.4 Hz) HRV (HF-HRV) and low frequency (0.04–0.15 Hz) HRV
(LF-HRV). Up to three 5 min epochs obtained during the home inter-
view were averaged to generate an aggregate value. Both indicators
were negatively skewed, and were log transformed before analysis.
Cortisol secretion
Cortisol output was assessed by measuring the profile of salivary cor-
tisol over a day. Salivary sampling with salivettes (Sarstedt, Leicester,
UK) was explained and practiced during the test session in the patient’s
home. Patients were asked to hold the cotton dental roll in their
mouths until saturated (for 2 min) at six times: immediately after
waking, 30 min later, 10:00–10:30 , 14:00–14:30 , 19:00–19:30 h, and
then just before bedtime. They also recorded the exact time of
sample collection and the time of waking. Patients were instructed
to avoid caffeine and acidic drinks, smoking, tooth brushing, eating,
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and drinking for 15 min before collecting saliva. Salivettes were stored
in domestic refrigerators before posting them back to the laboratory.
Patients who did not return their samples within 2 weeks were sent
reminders and replacement salivettes if necessary. Saliva samples
were sent to the Technical University Dresden for the analysis of cor-
tisol using a commercial immunoassay with chemiluminescence detec-
tion (CLIA; IBL-Hamburg, Germany). Inter- and intra-assay coefficients
of variation were ,8%.
Statistical analysis
The demographic and clinical characteristics of patients reporting low,
moderate, and intense distress and fear were compared using analysis
of covariance for continuous and x2 tests for categorical variables.
Associations between fear of dying and TNFa during ACS were
tested with logistic regression, assessing the odds of a TNFa value in
the upper tertile (≥12 pg/pl) in relation to fear of dying, with age,
gender, marital status, ethnicity, social deprivation (SES), statin, and
aspirin use prior to admission, pain during the ACS, GRACE score,
and days spent in hospital as covariates. Additional analyses included
individual components of GRACE scores (e.g. heart failure and
history of MI), but did not alter the results and so are not described
here. The relationship between TNFa and fear of dying and HRV
was analysed by means of multiple regression on RMSSD and
HF-HRV; in addition to the covariates detailed above, medication at
the time of HRV assessment with beta-blockers, statins, renin2
angiotensin medications (including angiotensin-converting enzyme
and receptor blockers) and platelet medications were included in
the models. Cortisol output was analysed by computing the area
under the curve (AUC) for the day.22 The distributions of both HRV
and cortisol AUC were skewed and so log transformed before analysis.
Data were analysed using SPSS v18.0, and all analyses involved two-
tailed tests.
Attrition analysis
Of the 208 patients in this study, 161 were interviewed at home 3
weeks after their ACS, and satisfactory HRV data were obtained
from 106 and cortisol from 110. Reasons for not participating in the
home interview included refusal (55%), further health problems (read-
mission, cognitive impairment, 16%) or failure to establish contact
despite repeated attempts (29%). Comparison of patients who were
included and excluded from the analysis showed no differences in
age, gender, ethnicity, type of ACS, clinical measures, fear of dying,
or TNFa on admission. However, individuals who failed to provide
data at the 3-week assessment point were more likely to be unmarried
(P ¼ 0.005) and of lower SES (P ¼ 0.019).
Results
Intense distress and fear of dying was reported by 45 (21.6%)
patients, moderate distress by 116 (55.8%), and low distress and
fear of dying by 47 (22.6%). Table 1 details the characteristics of
patients in the three categories. There were no gender or ethnicity
differences, or differences related to place of birth. But patients
who experienced intense distress and fear of dying were
younger (P ¼ 0.017), more likely to be unmarried (P ¼ 0.018),
and of lower SES (P ¼ 0.006). The majority of patients suffered a
STEMI, but intense distress and fear of dying was not related to
clinical cardiological factors. GRACE scores tended to be lower
in patients with intense distress and fear (P ¼ 0.056), but this
was no longer significant after age had been taken into account
(P ¼ 0.62). There were no differences in peak CK or in the
number of coronary vessels with significant stenosis. However,
patients who reported intense distress and fear of dying experi-
enced greater acute pain during the ACS (P ¼ 0.019). The majority
(72%) of patients underwent percutaneous coronary interventions,
21.7% were managed medically, and 6.3% were referred for coron-
ary artery bypass graft. Patient management was not related to dis-
tress and fear of dying.
Fear of dying and tumour necrosis factor
a during acute coronary syndrome
There were marked variations in plasma TNFa levels during hospi-
tal admission, ranging from 2.40 to 61.80 pg/mL, with 32.4% having
values ≥12 pg/mL. A positive association was observed between
acute distress and fear of dying and TNFa during hospital admis-
sion, illustrated in Figure 1, with proportions having values
≥12 pg/mL of 19.8, 31.1, and 51.5% in the low-, moderate-, and
high-fear-of-dying groups, respectively. Compared with the
low-fear-of-dying group, the odds of TNFa ≥12 pg/mL were
4.67 (95% confidence intervals (C.I.) 1.60–13.66, P ¼ 0.005) in
the high- compared with lower-distress and fear-of-dying group,
adjusting for age, gender, marital status, ethnicity, social depri-
vation, statin, and aspirin use prior to admission, pain during the
ACS, GRACE score and days spent in hospital. The same associ-
ation was observed when TNFa was analysed as a continuous
variable.
Tumour necrosis factor a and heart rate
variability
Significant associations were observed between TNFa during ACS
and reduced HRV 3 weeks later (Table 2). Effects were apparent
for HRV assessed in the time (RMSSD) and frequency domain
(HF-HRV and LF-HRV), and were independent of age, gender,
marital status, ethnicity, social deprivation, GRACE score, days
spent in hospital, and medication with beta-blockers, statins, platelet,
and renin2angiotensin medications (Table 2). The regression coeffi-
cient for TNFa on RMSSD was –0.449 (C.I. 20.772– 2 0.125, P ¼
0.007) and on HF-HRV was 20.823 (C.I. 21.44– 2 0.205, P ¼
0.010), while LF-HRV was positively associated with TNFa (0.003,
C.I. 0.001–0.006, P ¼ 0.002). The other independent correlates of
reduced HRV were being single as opposed to married, and
number of days spent in hospital before discharge. There was no
association between fear of dying and HRV.
Fear of dying and cortisol output
Salivary cortisol showed a typical diurnal profile, being high on
waking, increasing in the first 30 min after waking, and then
falling over the remainder of the day. The cortisol AUC was inver-
sely associated with distress and fear of dying, after controlling for
age, gender, marital status, ethnicity, social deprivation, GRACE
score, smoking status, statins on admission, and beta-blockers at
the time of testing (P ¼ 0.040). This result is illustrated in
Figure 2, contrasting individuals who reported low and high distress
and fear of dying, where it is apparent that cortisol output was sub-
stantially reduced in patients who had experienced intense fear of
dying. Cortisol output was not related to TNFa during ACS.
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Discussion
The purpose of this study was to investigate links between acute
emotional and acute inflammatory responses to ACS, and to test
their associations with cardiac autonomic control and cortisol
secretion. We found that intense distress and fear of dying was
experienced by one in five patients, and was positively related to
the levels of plasma TNFa recorded during ACS. This association
was independent of demographic and clinical variables. TNFa on
admission in turn correlated with reduced HRV, a potent indicator
of cardiac vulnerability,23,24 3 weeks later. Fear of dying was related
to reduced cortisol output at the same time point, a response that
could exacerbate heightened inflammation, but was not related to
HRV.
The distribution of ratings of acute distress and fear of dying
were similar to those we reported in an earlier cohort of ACS
patients.2 In the previous study, 40/184 (21.7%) of patients
reported intense distress and fear of dying, while 95 (51.6%)
experienced moderate distress. This compares with 45/208
(21.6%) reporting intense distress and fear of dying in the
present study, and 116 (55.8%) having moderate distress. We repli-
cated associations between acute distress and fear of dying and
lower SES and greater chest pain.2 But in addition, being unmarried
and relatively young were relevant (Table 1). Interestingly, acute
distress and fear of dying were not related to previous experience
of MI or to indicators of the clinical severity of the cardiac event. It
appears that acute distress and fear of dying may be stimulated by
symptomatic experience during ACS, while being accentuated in
more socially isolated and economically deprived patients.
The TNFa values recorded on admission were markedly elev-
ated compared with levels in healthy individuals, with one-third
of patients having levels ≥12 pg/mL, and only 5% showing values
within two standard deviations of those measured in previous
studies of healthy adults of comparable age.25 The processes
underlying the positive association between acute distress and
fear of dying and TNFa observed in this study are uncertain.
The relationship was independent of sociodemographic factors
and the severity of the cardiac event. The association is unlikely
to be causal. Although acute mental stress stimulates increases in
TNFa,9 the levels observed during ACS are substantially greater
than those recorded in any previous studies of mental stress. Con-
versely, even though systemic inflammation stimulates disturbances
in mood as part of the sickness behaviour syndrome,10 effects are
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Table 1 Factors associated with distress and fear of dying during acute coronary syndrome
Distress and fear of dying P
Low (n5 47) Moderate (n 5 116) High (n5 45)
Men/women 40/7 99/17 36/9 0.51
Age 61.79 + 11.9 60.00 + 10.8 55.38 + 11.3 0.017
Ethnicity (white) 37 (78.7%) 102 (87.9%) 35 (77.8%) 0.17
Married 34 (72.3%) 85 (73.3%) 22 (48.9%) 0.018
Social deprivation
Low 33 (70.2%) 83 (73.5%) 19 (43.2%) 0.006
Intermediate 10 (21.3%) 20 (17.7%) 15 (34.1%)
High 7 (8.5%) 10 (8.8%) 10 (22.7%)
Previous MI 6 (12.8%) 19 (16.4%) 4 (8.9%) 0.43
Statins prior to admission 37 (78.7%) 77 (66.4%) 35 (77.8%) 0.16
ST elevation MI 41 (87.2%) 105 (90.5%) 41 (91.1%) 0.54
Symptoms attributed to heart 11 (23.4%) 34 (29.8%) 18 (40.0%) 0.086
Pain during ACS 6.49 + 2.6 7.17 + 2.1 7.91 + 2.79 0.019
GRACE score 97.28 + 26.4 91.61 + 24.6 84.24 + 28.3 0.056
Mean CK (U/L) 1729.7 + 1644 1830.0 + 1527 2066.5 + 2208 0.62
Stenosed vessels 2.08 + 0.90 1.83 + 0.84 1.80 + 0.89 0.18
Days in hospital 5.55 + 3.23 5.34 + 4.35 5.13 + 3.42 0.42
Figure 1 Proportion of patients with tumour necrosis factor a
values ≥ 12 pl/mL reporting low, moderate, or intense distress
and fear of dying. Values are adjusted for age, gender, ethnicity,
marital status, social deprivation, statin use on admission,
GRACE score, number of days in hospital, and pain intensity.
Error bars are standard error of the mean .
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typically manifest as increases in fatigue and depressed mood
rather than extreme fear or anxiety. Nevertheless, the acute
emotional and inflammatory responses may be linked as related
manifestations of an integrated biobehavioural response to
severe cardiac injury.
Although ACS is associated with inflammatory responses that
can be indexed by a number of markers, we focused on TNFa
because of its known relationship with HRV through the inflamma-
tory reflex.14 There appears to be a reciprocal association
between TNFa and HRV: stimulation of the vagus (promoting
heightened HRV) inhibits TNFa production through action on
the nicotinic acetylcholine receptor alpha7 subunit,26 while
TNFa administration reduces HRV.15 An inverse association
between TNFa and HRV has previously been observed in cross-
sectional studies of community samples27 and patients with CHD
and heart failure.28 Provocation of inflammation using influenza
vaccination has been shown to reduce HRV in people with type
2 diabetes.29 The present findings extend these observations in
demonstrating a prospective association between TNFa during
ACS and HRV 3 weeks later that was independent of clinical and
demographic factors including medication. The magnitude of
inflammation during ACS may be an additional factor determining
cardiac autonomic dysregulation in the post-ACS phase.
Cortisol secretion arises through activation of the
hypothalamic2pituitary2adrenocortical axis, and is a key stress
hormone. Elevated levels of cortisol are associated with a range
of central nervous system, metabolic, endocrine, and cardiovascu-
lar health problems.30 However, some stressful experiences such
as early-life adversity are correlated with diminished cortisol
responses.31 Patients with inflammatory disorders show blunted
cortisol responsivity,32 and in healthy individuals greater cortisol
stress responsivity is correlated with less inflammatory response.33
The reduced cortisol output over the day among patients who
experienced intense distress and fear of dying may therefore
reflect dysregulation of neuroendocrine responses that limit
inflammation, promoting adverse outcomes following ACS.
Interpretation of these findings must take into account the drop
out from study. Attrition analyses showed that participation in the
3-week home interview was 77%, and was lower in unmarried and
lower SES patients. Such individuals are frequently more likely to
withdraw from medical research and population surveys, but
importantly, they did not differ from the remainder on the key
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Table 2 Regression of tumour necrosis factor a and covariates on heart rate variability. Unstandardized regression
coefficient B and 95% confidence intervals
RMSSD HF-HRV LF-HRV
B (95% C.I.) P B (95% C.I.) P B (95% C.I.) P
Age 0.008 (20.017–0.034) 0.51 0.027 (20.021–0.075) 0.27 20.005 (20.011–0.001) 0.12
Gendera 0.009 (20.493–0.511) 0.97 0.202 (20.757–1.16) 0.68 20.067 (20.192–0.058) 0.29
Ethnicityb 0.063 (20.362–0.487) 0.77 0.078 (20.734–0.890) 0.85 0.041 (20.147–0.064) 0.44
Marital statusc 20.396 (20.767–0.024) 0.037 20.967 (21.68–0.257) 0.008 0.110 (0.017–0.203) 0.020
Social deprivationd 20.039 (20.283–0.205) 0.75 20.001 (20.468–0.466) 0.99 20.047 (20.107–0.014) 0.13
GRACE score 20.006 (20.018–0.005) 0.28 20.016 (20.038–0.005) 0.13 0.001 (20.003–0.003) 0.86
Days in hospital 0.360 (0.018–0.703) 0.039 0.667 (0.012–1.32) 0.046 20.007 (20.094–0.081) 0.88
Beta-blockers 20.227 (20.609–0.154) 0.24 20.351 (21.08–0.379) 0.34 0.014 (20.080–0.108) 0.77
Statins 0.463 (20.203–1.13) 0.17 0.371 (20.902–1.64) 0.56 0.039 (20.126–0.204) 0.64
Renin2angiotensin medications 0.187 (20.328–0.702) 0.47 0.623 (20.362–1.61) 0.21 0.104 (20.024–0.232) 0.11
Platelet medication 0.994 (20.362–0.487) 0.25 2.131 (21.15–5.41) 0.20 20.192 (20.615–0.231) 0.37
TNFa during admission 20.449 (20.772–0.125) 0.007 20.823 (21.44–0.205) 0.010 0.003 (0.001–0.006) 0.002
aMen reference group;
bWhite European reference group;
cMarried reference group;
dLow-deprivation reference group.
Figure 2 Salivary cortisol profiles over the day in patients
experiencing low (dashed line), moderate (dotted line), or
intense distress and fear of dying (solid line). Samples were
obtained on waking (wake), 30 min later (w + 30), then at
10:00 h, 14:00 h, 19:00 h, and at bedtime. Values adjusted for
age, gender, ethnicity, marital status, social deprivation, GRACE
score, statins on admission, and smoking status. Error bars are
standard error of the mean.
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aspects of the present study, namely fear of dying and inflammatory
responses. The sample contained a high proportion of STEMI,
possibly because of selection factors such as excluding patients
who suffered from comorbidities that might affect mood or inflam-
mation. This may have eliminated a higher proportion of individuals
with other types of ACS, limiting the generalizability of results
beyond STEMI presentation. Further validation is therefore
required for patients who experienced non-STEMI or unstable
angina. Additional limitations of this study include the small
number of women and ethnic minority patients, which restricts
the generalizability of the findings. We did not assess inflammation
at the 3-week follow-up but only during hospitalization, and so
cannot confirm that lower cortisol was associated with persistent
inflammation. Additional clinical variables such as ejection fraction
might have helped explain the results, but data were incomplete.
Heart rate variability was not monitored under standardized clini-
cal conditions, but in patients’ own homes, and the time of day was
not controlled. Finally, although serial blood samples were
obtained over consecutive days of hospitalization from some
patients, data were incomplete so we were not able to track the
profile of inflammatory responses over time.
In conclusion, heightened inflammation during ACS and intense
distress and fear of dying may be related manifestations of an acute
biobehavioural response. The association between the two indi-
cates a linkage between emotional and inflammatory responses
during ACS that is independent of background characteristics
and other aspects of clinical disease. They were both related to
biological responses relevant to longer-term risk. These findings
may help understand the reciprocal relationship between psycho-
logical and biological factors in acute heart disease, raising the
possibility of new avenues for patient management.
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A monstrous aneurysm of the descending aorta as a sole manifestation
of tertiary syphilis treated endovascularly
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In May 2010, a 65-year-old female went to
her family doctor complaining about per-
sistent epigastric discomfort and back
pain. X-rays were done and surprisingly
showed a widened mediastinum. Suspect-
ing an aortic aneurysm as a rare cause for
the patient’s epigastric and back-pain
symptoms, an angio-CT was performed.
The CT revealed a monstrous aneurysm
of the thoracic descending aorta with
thickened wall and intraluminal thrombo-
tic bedding, compressing the oesophagus
and the heart (Panel A).
The patient was then referred to our
university interdisciplinary clinic for
aortic disease. On evaluation in our
institution, the patient confirmed the
earlier symptoms. She denied a family
history of aortic disease and had not
experienced symptoms of arteritis. To
exclude active vasculitis, a PET-CT was
done, which did not show any enhanced
uptake denoting any inflammatory
activity (Panel B). The serological
tests, performed to reveal the under-
lying pathology, surprisingly revealed
positive Treponema pallidum haemag-
glutination assay (TPHA) and Venereal
Disease Research Laboratory (VDRL) tests, as well as a positive Syphilis-Titre (IgG positive, IgM negative) which led to the diagnosis
of late latent syphilis with syphilitic aortitis. After confirmation of diagnosis, the patient received intravenous penicillin therapy for 3
weeks. Based on the general condition of the patient and the high risk of an operative intervention on an aneurysmatic descending
aorta of that size, the aneurysm was successfully treated by endovascular stenting of the descending aorta with excellent results
(Panels C and D). The patient recovered fully, and went home symptom free with a successfully treated aneurysmatic aorta.
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